Literature DB >> 27477148

Towards elimination of viral hepatitis by 2030.

.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27477148     DOI： 10.1016/S0140-6736(16)31144-8

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  10 in total

1.  Increasing the Awareness of the General Population: An Important Step in Elimination Programs of Viral Hepatitis.

Authors:  Hamidreza Karimi-Sari; Maryam Tajik; Mohammad Ehsan Bayatpoor; Seyed Moayed Alavian
Journal:  Am J Gastroenterol       Date:  2017-02       Impact factor: 10.864

2.  Therapy with Oral Directly Acting Agents in Hepatitis C Infection Is Associated with Reduction in Fibrosis and Increase in Hepatic Steatosis on Transient Elastography.

Authors:  Gyanranjan Rout; Baibaswata Nayak; Arpan H Patel; Deepak Gunjan; Vishwajeet Singh; Saurabh Kedia
Journal:  J Clin Exp Hepatol       Date:  2018-06-21

Review 3.  Current status and strategies for viral hepatitis control in Korea.

Authors:  Dong Hyun Sinn; Eun Ju Cho; Ji Hoon Kim; Do Young Kim; Yoon Jun Kim; Moon Seok Choi
Journal:  Clin Mol Hepatol       Date:  2017-09-19

4.  Direct-acting antiviral treatment for chronic hepatitis C in people who use drugs in a real-world setting.

Authors:  Kanellos Rafail Koustenis; Olga Anagnostou; Hariklia Kranidioti; Sofia Vasileiadi; Pinelopi Antonakaki; Evangelia Koutli; Paris Pantsas; Melanie Deutsch; Spilios Manolakopoulos
Journal:  Ann Gastroenterol       Date:  2020-01-20

5.  CRISPR/Cas13-assisted hepatitis B virus covalently closed circular DNA detection.

Authors:  Xiangying Zhang; Yuan Tian; Ling Xu; Zihao Fan; Yaling Cao; Yingmin Ma; Hao Li; Feng Ren
Journal:  Hepatol Int       Date:  2022-03-17       Impact factor: 9.029

6.  Impact of the COVID-19 pandemic on hepatitis B and C elimination: An EASL survey.

Authors:  Loreta A Kondili; Maria Buti; Mar Riveiro-Barciela; Mojca Maticic; Francesco Negro; Thomas Berg; Antonio Craxì
Journal:  JHEP Rep       Date:  2022-07-27

7.  World hepatitis day in Burkina Faso, 2017: seroprevalence and vaccination against hepatitis B virus to achieve the 2030 elimination goal.

Authors:  Birama Diarra; Albert Theophane Yonli; Abdoul Karim Ouattara; Theodora Mahoukèdè Zohoncon; Lassina Traore; Christelle Nadembega; Dorcas Obiri-Yeboah; Justine Yara; Virginio Pietra; Paul Ouedraogo; Alain Bougouma; Rokia Sanogo; Jacques Simpore
Journal:  Virol J       Date:  2018-08-06       Impact factor: 4.099

8.  Real-world Efficacy of Direct-Acting Antiviral Therapy for HCV Infection Affecting People Who Inject Drugs Delivered in a Multidisciplinary Setting.

Authors:  Arshia Alimohammadi; Julie Holeksa; Astou Thiam; David Truong; Brian Conway
Journal:  Open Forum Infect Dis       Date:  2018-05-23       Impact factor: 3.835

Review 9.  Thienopyrimidine: A Promising Scaffold to Access Anti-Infective Agents.

Authors:  Prisca Lagardère; Cyril Fersing; Nicolas Masurier; Vincent Lisowski
Journal:  Pharmaceuticals (Basel)       Date:  2021-12-27

Review 10.  Progress and challenges in the comprehensive management of chronic viral hepatitis: Key ways to achieve the elimination.

Authors:  Fátima Higuera-de la Tijera; Alfredo Servín-Caamaño; Luis Servín-Abad
Journal:  World J Gastroenterol       Date:  2021-07-14       Impact factor: 5.742
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.